Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Metastatic Non-Small Cell Lung Cancer
NCT00092001Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sunitinib in non-small cell lung cancer (NSCLC), sponsored by Pfizer. Started Jan 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00092001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092001.